TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in TC BioPharm (Holdings) plc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TCBP is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023
- Institutional holders
- 12
- +4 vs. Q3 2024
- Shares held
- 54.9K
- +45.6K (+489.3%) vs. Q3 2024
- Total value
- $34.8K
- −$14.0K (−28.7%) vs. Q3 2024
- New holders
- 8
- 2 more added
- Sold out
- 4
- 0 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $34 |
| Q1 2025 | 1 | $34 |
| Q4 2024 | 12 | $34.8K |
| Q3 2024 | 8 | $48.9K |
| Q2 2024 | 8 | $77.0K |
| Q1 2024 | 5 | $42.6K |
| Q4 2023 | 4 | $243.8K |
| Q3 2023 | 12 | $179.6K |
| Q2 2023 | 6 | $380.1K |
| Q1 2023 | 4 | $207.3K |
| Q4 2022 | 2 | $323.8K |
| Q3 2022 | 5 | $141.0K |
| Q2 2022 | 5 | $166.0K |
| Q1 2022 | 8 | $399.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding TC BioPharm (Holdings) plc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toth Financial Advisory Corp | 30 | $20 | 0.00% | +30 | New |
| Wells Fargo & Company | 140 | $90 | 0.00% | +135+2,700.0% | Added |
| Truvestments Capital LLC | 200 | $129 | 0.00% | +200 | New |
| New England Capital Financial Advisors LLC | 201 | $130 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 236 | $152 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,164 | $749 | 0.00% | +1,081+1,302.4% | Added |
| GAMMA Investing LLC | 1,225 | $790 | 0.00% | +1,225 | New |
| JPMorgan Chase & Co | 1,679 | $1.08K | 0.00% | +1,679 | New |
| SBI Securities Co., Ltd. | 4,127 | $2.66K | 0.00% | +4,127 | New |
| HRT Financial LP | 14,316 | $9.00K | 0.00% | +14,316 | New |
| Virtu Financial LLC | 16,042 | $10.0K | 0.00% | +16,042 | New |
| Cubist Systematic Strategies, LLC | 15,553 | $10.0K | 0.00% | +15,553 | New |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −492−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Sanctuary Wealth Management, L.L.C. | 0 | $0 | 0.00% | −12−100.0% | Sold out |